Innovative Laser and Fiber System for Non-Toxic, Efficient and Cost-Effective Treatment of Cancer
Sector: Nuclear • Location: Germany
Source: EU Funding & Tenders Portal
"Our aim with this proposal is to bring the desired technology for a non-toxic, efficient and cost-effective cancer treatment. Basically, all cytotoxic drugs (chemotherapy) and radiation lead to apoptosis, the programmed cell death of tumor cells. These techniques on the other hand have well documented side effects like losing hair, teeth, damaged quality of life effecting lives of more than 14M c
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | ended |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | "Our aim with this proposal is to bring the desired technology for a non-toxic, efficient and cost-effective cancer treatment. Basically, all cytotoxic drugs (chemotherapy) and radiation lead to apoptosis, the programmed cell death of tumor cells. These techniques on the other hand have well documented side effects like losing hair, teeth, damaged quality of life effecting lives of more than 14M cancer patients and their families worldwide. LoF revolutionizes ""non-toxic"" cancer treatment with her innovative laser probes and systems serving oncologists tasked with saving lives by developing and applying the most effective therapies. Our state-of-the-art laser probes and systems form a feedback loop and enable oncologists for the “first time” to monitor absorbed dose to the tissue in real time which is decisive for the treatment efficacy. Cancer cost the EU €126 billion in 2013, with health care accounting for €51 billion (40% of the total cost) for post-treatments. EU needs better, effective solutions to drive costs down. With our solution which is the subject of this proposal we offer a potential cost-saving of 60%. The market potential for the envisaged the clinical applications is based on current cases at around 2.24 billion euros worldwide. Our innovation opens the door to new treatment applications and could be used to treat up to 5 million people per year from 2022." |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |
